Marescau B - Search Results

1

Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Engelborghs S, Marescau B, De Deyn PP. Engelborghs S, et al. Among authors: marescau b. Neurochem Res. 2003 Aug;28(8):1145-50. doi: 10.1023/a:1024255208563. Neurochem Res. 2003. PMID: 12834252

2

Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.

Brouns R, Marescau B, Possemiers I, Sheorajpanday R, De Deyn PP. Brouns R, et al. Among authors: marescau b. Neurochem Res. 2009 Sep;34(9):1642-9. doi: 10.1007/s11064-009-9954-3. Epub 2009 Mar 19. Neurochem Res. 2009. PMID: 19296217

3

Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.

Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Van Dam D, et al. Among authors: marescau b. Neurochem Int. 2005 Apr;46(5):409-22. doi: 10.1016/j.neuint.2004.11.005. Epub 2005 Jan 17. Neurochem Int. 2005. PMID: 15737439

4

Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency.

De Deyn PP, Marescau B, Cuykens JJ, Van Gorp L, Lowenthal A, De Potter WP. De Deyn PP, et al. Among authors: marescau b. Clin Chim Acta. 1987 Jul 30;167(1):81-8. doi: 10.1016/0009-8981(87)90088-x. Clin Chim Acta. 1987. PMID: 3665089

5

Consequences of renal mass reduction on amino acid and biogenic amine levels in nephrectomized mice.

Al Banchaabouchi M, Marescau B, D'Hooge R, Engelborghs S, De Deyn PP. Al Banchaabouchi M, et al. Among authors: marescau b. Amino Acids. 2000;18(3):265-77. doi: 10.1007/s007260050023. Amino Acids. 2000. PMID: 10901623

6

Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain.

Van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn PP. Van Dam D, et al. Among authors: marescau b. Amino Acids. 2005 Jun;28(4):377-87. doi: 10.1007/s00726-005-0208-7. Epub 2005 May 17. Amino Acids. 2005. PMID: 15889219

7

Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.

Marescau B, De Deyn PP, Lowenthal A, Qureshi IA, Antonozzi I, Bachmann C, Cederbaum SD, Cerone R, Chamoles N, Colombo JP, et al. Marescau B, et al. Pediatr Res. 1990 Mar;27(3):297-303. doi: 10.1203/00006450-199003000-00020. Pediatr Res. 1990. PMID: 1690873

8

Impaired cognitive performance in ornithine transcarbamylase-deficient mice on arginine-free diet.

D'Hooge R, Marescau B, Qureshi IA, De Deyn PP. D'Hooge R, et al. Among authors: marescau b. Brain Res. 2000 Sep 8;876(1-2):1-9. doi: 10.1016/s0006-8993(00)02589-0. Brain Res. 2000. PMID: 10973586

9

Endogenous guanidino compounds as uremic neurotoxins.

De Deyn PP, D'Hooge R, Van Bogaert PP, Marescau B. De Deyn PP, et al. Among authors: marescau b. Kidney Int Suppl. 2001 Feb;78:S77-83. doi: 10.1046/j.1523-1755.2001.59780077.x. Kidney Int Suppl. 2001. PMID: 11168988 Free article. Review.

10

Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.

Al Banchaabouchi M, Marescau B, Van Marck E, D'hooge R, De Deyn PP. Al Banchaabouchi M, et al. Among authors: marescau b. Metabolism. 2001 Dec;50(12):1418-25. doi: 10.1053/meta.2001.26763. Metabolism. 2001. PMID: 11735086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters